₃₈Hideo Yagita

Hideo Yagita Articles (38) [selected PubMed articles for the year 2005 with the links to a full text at PubMed]

• Too much data, only first 100 publications and/or coauthors will be displayed. Unabridged data can only be viewed as XML or CSV documents.

• CD24 expression causes the acquisition of multiple cellular properties associated with tumor growth and metastasis. (2005) >>

  Forschungszentrum Karlsruhe, Institut für Toxikologie und Genetik, Karlsruhe, Germany.

  ₁Kroese, Frans, ₂Orend, Gertraud, ₁Baumann, Petra, ₂Sleeman, Jonathan P, ₃₈Yagita, Hideo, ₁Uede, Toshi, ₄Chiquet-Ehrismann, Ruth, ₁Cremers, Natascha.

• The interaction between ICOS and B7RP-1 is not required for the development of experimental murine allergic conjunctivitis. (2005) >>

  Department of Ophthalmology, Kochi Medical School, Kohasu, Oko-cho, Nankoku-city 783-8505, Japan.

  ₁₁Ueno, Hisayuki, ₁₅Fukushima, Atsuki, ₃₈Yagita, Hideo, ₉Yamaguchi, Tomoko, ₈Ishida, Waka, ₉Fukata, Kazuyo.

• CD4+ T-cell death induced by infectious and noninfectious HIV-1: role of type 1 interferon-dependent, TRAIL/DR5-mediated apoptosis. (2005) >>

  Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.

  ₄Hardy, Andrew W, ₂Chougnet, Claire, ₃₈Yagita, Hideo, ₆Boasso, Adriano, ₄Herbeuval, Jean-Philippe, ₅Shearer, Gene M, ₄Dolan, Matthew J, ₅Grivel, Jean-Charles, ₁₃Lifson, Jeffrey D.

• Immune responses against a single CD8+-T-cell epitope induced by virus vector vaccination can successfully control Trypanosoma cruzi infection. (2005) >>

  Atopy Research Center, Department of Parasitology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.

  ₄Ohwada, Akihiko, ₉Akiba, Hisaya, ₂Ohyanagi-Hara, Mutsuko, ₃₈Yagita, Hideo, ₈Yoshida, Ayako, ₃₇Ogawa, Hideoki, ₆Kobayashi, Seiki, ₂₇Takeuchi, Tsutomu, ₄Matsumoto, Yasunobu, ₂Miyahira, Yasushi, ₃₅Okumura, Ko, ₇Takashima, Yasuhiro.

• Modulation of surgical fibrosis by microbial zwitterionic polysaccharides. (2005) >>

  Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

  ₄Tzianabos, Arthur O, ₁Chung, Doo R, ₂Kalka-Moll, Wiltrud M, ₃₈Yagita, Hideo, ₁₂Sharpe, Arlene H, ₁₇Sayegh, Mohamed H, ₁Ruiz-Perez, Begonia, ₁₁Kasper, Dennis L.

• Virus-induced polyclonal B cell activation improves protective CTL memory via retained CD27 expression on memory CTL. (2005) >>

  Department of Clinical Research, University of Berne, Bern, Switzerland.

  ₁Mumprecht, Sabine, ₃₈Yagita, Hideo, ₂Pinschewer, Daniel D, ₃Borst, Jannie, ₃Krautwald, Stefan, ₂Ochsenbein, Adrian F, ₁Matter, Matthias, ₁Pavelic, Viktor.

• Engagement of 4-1BB inhibits the development of experimental allergic conjunctivitis in mice. (2005) >>

  Department of Ophthalmology, Kochi Medical School, Nankoku-city, Japan.

  ₁₁Ueno, Hisayuki, ₁₅Fukushima, Atsuki, ₃₈Yagita, Hideo, ₉Yamaguchi, Tomoko, ₈Ishida, Waka, ₄Mittler, Robert S, ₉Fukata, Kazuyo.

• TNF-related apoptosis-inducing ligand (TRAIL)/Apo2L suppresses experimental autoimmune encephalomyelitis in mice. (2005) >>

  Cancer Immunology Program, Sir Donald and Lady Trescowthick Laboratories, Peter MacCallum Cancer Centre, Victoria, Australia.

  ₃₁Smyth, Mark J, ₇Cretney, Erika, ₈Ashkenazi, Avi, ₃₈Yagita, Hideo, ₁McQualter, Jonathan L, ₃Grewal, Iqbal S, ₄Bernard, Claude C A, ₂Kayagaki, Nobuhiko.

• Tumor necrosis factor alpha (TNFalpha) induces the unfolded protein response (UPR) in a reactive oxygen species (ROS)-dependent fashion, and the UPR counteracts ROS accumulation by TNFalpha. (2005) >>

  Department of Immunology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421.

  ₄Harding, Heather, ₇Nakano, Hiroyasu, ₁Sakon-Komazawa, Sachiko, ₃₈Yagita, Hideo, ₁Piao, Jiang-Hu, ₆Kojima, Yuko, ₃Mori, Kazutoshi, ₂Nakajima, Akihito, ₃₅Okumura, Ko, ₁Xue, Xin.

• The role of ICOS in the CXCR5+ follicular B helper T cell maintenance in vivo. (2005) >>

  Department of Immunology, Juntendo University School of Medicine, Tokyo, Japan.

  ₉Akiba, Hisaya, ₃Usui, Yoshihiko, ₃Ma, Juan, ₂Yamazaki, Tomohide, ₁₂Takeda, Kazuyoshi, ₃₈Yagita, Hideo, ₄Tezuka, Katsunari, ₆Kojima, Yuko, ₄Harada, Norihiro, ₃₅Okumura, Ko.

• Amelioration of acute graft-versus-host disease by NKG2A engagement on donor T cells. (2005) >>

  Department of Immunology, Niigata University School of Medicine, Niigata, Japan.

  ₆Kawamura, Hiroki, ₁Nisizawa, Tetsuro, ₃Vance, Russell E, ₃₈Yagita, Hideo, ₈Abo, Toru, ₅Raulet, David H, ₁Izumi, Nakako, ₂Miyaji, Chikako, ₃₅Okumura, Ko.

• Blockade of B7-H1 on macrophages suppresses CD4+ T cell proliferation by augmenting IFN-gamma-induced nitric oxide production. (2005) >>

  Department of Immunology, Juntendo University School of Medicine, Hongo, Tokyo, Japan.

  ₇Azuma, Miyuki, ₉Akiba, Hisaya, ₂Yamazaki, Tomohide, ₃₈Yagita, Hideo, ₃₅Okumura, Ko, ₂Koyanagi, Akemi.

• Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways. (2005) >>

  Department of Microbiology and Immunology, University of Miami School of Medicine, Miami, Florida 33101, USA.

  ₃Levy, Robert B, ₁Podack, Eckhard, ₃₈Yagita, Hideo, ₁Deyev, Vadim, ₂Shatry, Alwi, ₂₅Blazar, Bruce R, ₂Zimmerman, Zachary, ₂Mammolenti, Michele.

• Synergistic enhancement of TRAIL- and tumor necrosis factor alpha-induced cell death by a phenoxazine derivative. (2005) >>

  Department of Clinical Chemistry and Laboratory Medicine, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.

  ₃₈Yagita, Hideo, ₁Mizukami, Yoichi, ₁Aki, Toshihiko, ₃Okamoto, Mayumi, ₁₀Tanaka, Hirotoshi, ₁₀Kang, Dongchon, ₁Hara, Keiichi, ₂₃Nakamura, Hiroshi, ₁₁Hamasaki, Naotaka, ₆Tomoda, Akio.

• IFN-gamma-mediated negative feedback regulation of NKT-cell function by CD94/NKG2. (2005) >>

  Department of Immunology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.

  ₁₈Kinoshita, Katsuyuki, ₉Akiba, Hisaya, ₁₇Hayakawa, Yoshihiro, ₃₈Yagita, Hideo, ₁₂Takeda, Kazuyoshi, ₃Ota, Tsuyoshi, ₅Raulet, David H, ₆Ogasawara, Kouetsu, ₃₁Smyth, Mark J, ₈Ikarashi, Yoshinori, ₈Wakasugi, Hiro, ₁₀Miyake, Sachiko, ₁₆Yamamura, Takashi, ₂₄Kronenberg, Mitchell, ₃₅Okumura, Ko.

• Renal allograft rejection is prevented by adoptive transfer of anergic T cells in nonhuman primates. (2005) >>

  Department of Immunology, Juntendo University School of Medicine, Tokyo, Japan.

  ₁Bashuda, Hisashi, ₃₈Yagita, Hideo, ₃₄Shimizu, Akira, ₁Seino, Kenichiro, ₁Kimikawa, Masaaki, ₈Teraoka, Satoshi, ₁Kato, Yojiro, ₆Ono, Fumiko, ₃₅Okumura, Ko.

• A critical role for the programmed death ligand 1 in fetomaternal tolerance. (2005) >>

  Transplantation Research Center, Brigham and Women's Hospital and Children's Hospital Boston, Harvard Medical School, Boston, MA 02115, USA.

  ₇Azuma, Miyuki, ₇Noelle, Randolph J, ₃₈Yagita, Hideo, ₁Coyle, Anthony, ₁Ansari, Mohammed Javeed, ₆Khoury, Samia J, ₁₇Sayegh, Mohamed H, ₂Habicht, Antje, ₁Guleria, Indira, ₁Khosroshahi, Arezou, ₅Mellor, Andrew L.

• Beta2-microglobulin required for cell surface expression of blastocyst MHC. (2005) >>

  Department of Gynecology, Juntendo University School of Medicine, Tokyo 113-8421, Japan.

  ₄Tajima, Atsushi, ₁₈Kinoshita, Katsuyuki, ₃₈Yagita, Hideo, ₁Tanaka, Toshitaka, ₁Ebata, Tomohiko, ₃₅Okumura, Ko.

• Regulation of murine chronic colitis by CD4+CD25- programmed death-1+ T cells. (2005) >>

  Department of Gastroenterology and Hepatology, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan.

  ₉Akiba, Hisaya, ₁Nemoto, Yasuhiro, ₂₂Oshima, Shigeru, ₂Totsuka, Teruji, ₂Fujii, Rei, ₃₈Yagita, Hideo, ₁₉Watanabe, Mamoru, ₁₀Kanai, Takanori, ₃₅Okumura, Ko, ₂Koyanagi, Akemi, ₅Okamoto, Ryuichi, ₂Makita, Shin.

• TWEAK mediates anti-tumor effect of tumor-infiltrating macrophage. (2005) >>

  Department of Immunology, Juntendo University School of Medicine, Tokyo 113-8421, Japan.

  ₂Kaduka, Yuki, ₁₈Kinoshita, Katsuyuki, ₁₂Takeda, Kazuyoshi, ₃₈Yagita, Hideo, ₂Nakayama, Masafumi, ₃₅Okumura, Ko.

• Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo. (2005) >>

  Transplantation Research Center, Brigham and Women's Hospital and Children's Hospital Boston, MA 02115, USA.

  ₇Azuma, Miyuki, ₅Clarkson, Michael R, ₁Jurewicz, Mollie M, ₂Auchincloss, Hugh, ₃₈Yagita, Hideo, ₁₂Sharpe, Arlene H, ₃Ito, Toshiro, ₁₇Sayegh, Mohamed H, ₅Ueno, Takuya, ₃Najafian, Nader, ₂Yuan, Xueli.

• Structure and function of lipid rafts in human activated T cells. (2005) >>

  Department of Immunobiology, Medical Technology and Science, Osaka University Graduate School of Medicine, Suita, Osaka 565-0871, Japan.

  ₄Ohno-Iwashita, Yoshiko, ₁Kondo, Nami, ₃Inokuchi, Jin-ichi, ₃₈Yagita, Hideo, ₄Shimada, Yukiko, ₁Maruyama, Koji, ₁Tani-Ichi, Shizue, ₂Kabayama, Kazuya, ₂Nagafuku, Masakazu, ₉Kawano, Sunao, ₂Kosugi, Atsushi.

• Sequential activation of NKT cells and NK cells provides effective innate immunotherapy of cancer. (2005) >>

  Cancer Immunology Program, Trescowthick Laboratories, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia.

  ₃₁Smyth, Mark J, ₁₇Hayakawa, Yoshihiro, ₃₈Yagita, Hideo, ₁₄Godfrey, Dale I, ₄Wallace, Morgan E, ₇Nutt, Stephen L.

• Critical contribution of CD80 and CD86 to induction of anterior chamber-associated immune deviation. (2005) >>

  Department of Ophthalmology, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo 160-0023, Japan.

  ₉Akiba, Hisaya, ₁Tsukahara, Rintaro, ₃Usui, Yoshihiko, ₄Kezuka, Takeshi, ₁₂Takeda, Kazuyoshi, ₃₈Yagita, Hideo, ₄Takeuchi, Masaru, ₁₈Usui, Masahiko, ₃₅Okumura, Ko.

• Role of the ICOS-B7h costimulatory pathway in the pathophysiology of chronic allograft rejection. (2005) >>

  Department of Surgery, Nara Medical University School of Medicine, Kashihara, Nara, Japan.

  ₅Nomi, Takeo, ₃₈Yagita, Hideo, ₆Akashi, Satoru, ₉Ikeda, Naoya, ₁₇Sayegh, Mohamed H, ₉Sho, Masayuki, ₇Kanehiro, Hiromichi, ₆Tsurui, Yoshikazu, ₅Kuzumoto, Yukiyasu, ₇Kashizuka, Hisanori, ₈Mizuno, Takashi, ₁₆Nakajima, Yoshiyuki.

• E1A sensitizes cancer cells to TRAIL-induced apoptosis through enhancement of caspase activation. (2005) >>

  Department of Molecular and Cellular Oncology, Unit 108, The University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.

  ₃Lee, Dung-Fang, ₂Ping, Bo, ₃₈Yagita, Hideo, ₂Spohn, Bill, ₁₉Hung, Mien-Chie, ₂Wen, Yong, ₁Shao, Ruping, ₃₇Ding, Yi, ₆Xia, Weiya.

• Dengue virus-induced apoptosis in hepatic cells is partly mediated by Apo2 ligand/tumour necrosis factor-related apoptosis-inducing ligand. (2005) >>

  Division of Molecular Virology and Oncology, Graduate School of Medicine, University of the Ryukyus, Uehara 207, Nishihara, Okinawa 903-0215, Japan.

  ₁Saito, Mika, ₂Almasan, Alex, ₃₈Yagita, Hideo, ₄Tadano, Masayuki, ₂₀Mori, Naoki, ₅Tomita, Mariko, ₁₁Ohta, Takao, ₁Tamaki, Kazumi, ₇Matsuda, Takehiro.

• TRAIL-transduced dendritic cells protect mice from acute graft-versus-host disease and leukemia relapse. (2005) >>

  Laboratory for Dendritic Cell Immunobiology, Research Center for Allergy and Immunology, RIKEN Yokohama Institute, Kanagawa, Japan.

  ₇Kawasaki, Hiroshi, ₃₈Yagita, Hideo, ₉Sato, Katsuaki, ₃Yamashita, Naohide, ₅Matsuyama, Takami, ₁₇Baba, Masanori, ₃Nakaoka, Takashi, ₁₀Morimoto, Chikao.

• Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer. (2005) >>

  Department of Surgery, Nara Medical University School of Medicine, Nara, Japan.

  ₃₈Yagita, Hideo, ₉Sho, Masayuki, ₉Hamada, Kaoru, ₃Yamada, Yukishige, ₃Yane, Katsunari, ₆Tsurui, Yoshikazu, ₇Kashizuka, Hisanori, ₈Mizuno, Takashi, ₁₆Nakajima, Yoshiyuki, ₇Azuma, Miyuki, ₃Yoriki, Ryo, ₁Otsuki, Noriko, ₁Ohigashi, Yuichiro, ₁Tsushima, Fumihiko, ₉Ikeda, Naoya.

• Interleukin-10 but not transforming growth factor-beta is essential for generation and suppressor function of regulatory cells induced by intratracheal delivery of alloantigen. (2005) >>

  Department of Surgery, Teikyo University, Tokyo, Japan.

  ₃₈Yagita, Hideo, ₃Niimi, Masanori, ₁₀Ikeda, Yoshifumi, ₃Aramaki, Osamu, ₅Shirasugi, Nozomu, ₁₁Shimazu, Motohide, ₂Inoue, Fumihiko, ₄₈Kitajima, Masaki, ₃₅Okumura, Ko, ₂₀Takayama, Tadatoshi.

• Role of the programmed death-1 pathway in regulation of alloimmune responses in vivo. (2005) >>

  Transplantation Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

  ₇Azuma, Miyuki, ₅Clarkson, Michael R, ₂Sandner, Sigrid E, ₃₈Yagita, Hideo, ₉Turka, Laurence A, ₅Sánchez-Fueyo, Alberto, ₁₇Sayegh, Mohamed H, ₂Habicht, Antje, ₄Salama, Alan D, ₃Najafian, Nader, ₂Domenig, Christoph.

• TRAIL identifies immature natural killer cells in newborn mice and adult mouse liver. (2005) >>

  Department of Immunology, Juntendo University School of Medicine, 2-1-1 Hongo, Bukyou-ku, Tokyo 113-8421, Japan.

  ₃₁Smyth, Mark J, ₉Akiba, Hisaya, ₁₈Kinoshita, Katsuyuki, ₁₇Hayakawa, Yoshihiro, ₇Cretney, Erika, ₁₂Takeda, Kazuyoshi, ₃₈Yagita, Hideo, ₃Ota, Tsuyoshi, ₆Ogasawara, Kouetsu, ₃₅Okumura, Ko.

• Activation of NK cell cytotoxicity. (2005) >>

  Cancer Immunology Program, Trescowthick Laboratories, Peter MacCallum Cancer Centre, Vic. 8006, Australia.

  ₃₁Smyth, Mark J, ₃van Dommelen, Serani L H, ₁₇Hayakawa, Yoshihiro, ₇Cretney, Erika, ₅Degli-Esposti, Mariapia A, ₁Street, Shayna E A, ₁₂Takeda, Kazuyoshi, ₃₈Yagita, Hideo, ₂Kelly, Janice M, ₄Westwood, Jennifer A.

• ICOS costimulates invariant NKT cell activation. (2005) >>

  Department of Immunology, Juntendo University School of Medicine, Tokyo 113-8421, Japan.

  ₂Kaduka, Yuki, ₉Akiba, Hisaya, ₁₈Kinoshita, Katsuyuki, ₁₂Takeda, Kazuyoshi, ₃₈Yagita, Hideo, ₃Ota, Tsuyoshi, ₈Ikarashi, Yoshinori, ₈Wakasugi, Hiro, ₂₄Kronenberg, Mitchell, ₃₅Okumura, Ko, ₃Kaneda, Hiroshi.

• Resistance to Apo2 ligand (Apo2L)/tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis and constitutive expression of Apo2L/TRAIL in human T-cell leukemia virus type 1-infected T-cell lines. (2005) >>

  Division of Molecular Virology and Oncology, Graduate School of Medicine, University of the Ryukyus, 207 Uehara, Nishihara, Okinawa 903-0215, Japan.

  ₂Almasan, Alex, ₃₈Yagita, Hideo, ₂₀Mori, Naoki, ₄Uchihara, Jun-Nosuke, ₇Masuda, Masato, ₅Tomita, Mariko, ₁₁Ohta, Takao, ₇Matsuda, Takehiro, ₁₁Takasu, Nobuyuki, ₃Ohshiro, Kazuiku.

• CD70 signaling is critical for CD28-independent CD8+ T cell-mediated alloimmune responses in vivo. (2005) >>

  Transplantation Research Center, Brigham and Women's Hospital and Children's Hospital Boston, Harvard Medical School, Boston, MA 02115, USA.

  ₅Clarkson, Michael R, ₃₈Yagita, Hideo, ₂Sandner, Sigrid, ₁Chalasani, Geetha, ₃Ito, Toshiro, ₁Mandelbrot, Didier A, ₁₇Yamada, Akira, ₉Sho, Masayuki, ₁Kewalramani, Reshma, ₁₃Harada, Hiroshi, ₄Lakkis, Fadi G, ₂Auchincloss, Hugh, ₂Oshima, Hideo, ₁₂Sharpe, Arlene H, ₁₇Sayegh, Mohamed H, ₅Forman, John P, ₄Salama, Alan D, ₃Najafian, Nader.

• Induction of CD70 on dendritic cells through CD40 or TLR stimulation contributes to the development of CD8+ T cell responses in the absence of CD4+ T cells. (2005) >>

  Department of Pathology and Human Immune Therapy Center, University of Virginia, Charlottesville, VA 22908, USA.

  ₁Bullock, Timothy N J, ₃₈Yagita, Hideo.

• Mechanisms of tolerance induced by donor-specific transfusion and ICOS-B7h blockade in a model of CD4+ T-cell-mediated allograft rejection. (2005) >>

  Transplantation Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

  ₅Clarkson, Michael R, ₂Sandner, Sigrid E, ₃₈Yagita, Hideo, ₉Turka, Laurence A, ₅Sánchez-Fueyo, Alberto, ₁₇Sayegh, Mohamed H, ₄Salama, Alan D.